Vaxart, Inc. Available-for-sale Securities, Amortized Cost Basis
Vaxart, Inc. (VXRT) had Available-for-sale Securities, Amortized Cost Basis of $18.70 million as of 2017-12-31, per its 10-Q filed 2018-02-06.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAmortizedCost · last filed 2018-02-06
- 2017-12-31: Available-for-sale Securities, Amortized Cost Basis $18.70M.
- 2017-09-30: Available-for-sale Securities, Amortized Cost Basis $31.50M.
- 2017-06-30: Available-for-sale Securities, Amortized Cost Basis $31.80M.
- 2017-03-31: Available-for-sale Securities, Amortized Cost Basis $33.20M.
| Period end | Available-for-sale Securities, Amortized Cost Basis | Available-for-sale Securities, Amortized Cost Basis as first filed |
|---|---|---|
| 2017-12-31 | $18.70M 10-Q · filed 2018-02-06 | |
| 2017-09-30 | $31.50M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $31.80M 10-Q · filed 2018-02-06 | |
| 2017-03-31 | $33.20M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $21.80M 10-Q · filed 2017-02-06 | |
| 2016-09-30 | $21.80M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $20.70M 10-K · filed 2017-09-01 | |
| 2016-03-31 | $45.60M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $27.20 10-Q · filed 2016-02-08 | |
| 2015-06-30 | $20.70M 10-Q · filed 2016-11-08 | $27.20 10-Q · filed 2016-02-08 |
| 2014-06-30 | $46.90M 10-K · filed 2014-09-30 | |
| 2012-09-30 | $0.00 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $0.00 10-Q · filed 2012-08-09 | |
| 2011-12-31 | $2.08M 10-Q · filed 2012-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |